Ovid Therapeutics (OVID) Return on Capital Employed Growth (5y) (2022 - 2026)
Ovid Therapeutics (OVID) Return on Capital Employed Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Ovid Therapeutics | 120.41 Mn | -35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,991.00 |
| Dec 31, 2025 | 8,916.00 |
| Sep 30, 2025 | 8,862.00 |
| Jun 30, 2025 | 14,001.00 |
| Mar 31, 2025 | 3,690.00 |
| Dec 31, 2024 | 5,102.00 |
| Sep 30, 2024 | 8,273.00 |
| Jun 30, 2024 | 4,249.00 |
| Mar 31, 2024 | 6,119.00 |
| Dec 31, 2023 | 6,901.00 |
| Sep 30, 2023 | 5,038.00 |
| Jun 30, 2023 | 2,952.00 |
| Mar 31, 2023 | 1,902.00 |
| Dec 31, 2022 | 3,803.00 |